Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: Health cancer | History Defined

Small Trial Injecting Flu Vaccine Into Melanoma Tumors Found No Cancer Cells Left in 3 of 18 Patients

An early Ohio State trial found signs of tumor shrinkage after flu vaccine injections in melanoma patients, but the small, uncontrolled, non-peer-reviewed study does not establish effectiveness.

Medical Daily · 11h ago

Methylene Chloride Loses FDA Approval in Produce-Marking Inks as Three Solvents Leave Annatto, Paprika and Turmeric Colors

The FDA revoked approvals for methylene chloride in produce-marking inks and three solvents used to make certain food colors, while leaving decaf coffee use under review.

Medical Daily · 13h ago

Rybrevant Faspro Wins Accelerated Approval for Advanced Head and Neck Cancer After 42% of Trial Patients Responded

The FDA approved Rybrevant Faspro through its accelerated pathway after 42% of 102 patients with advanced head and neck cancer responded in the OrigAMI-4 trial.

Medical Daily · Nov 7

From analysis to the latest developments in health,
read the most diverse news in one place.

Prescription Omega-3 EPA Tied to Longer Survival After Colorectal Cancer Liver Surgery in Preliminary Trial

A U.K. phase 3 trial linked prescription EPA with higher five-year survival after surgery for colorectal cancer liver metastases, but it did not improve progression-free survival.

Medical Daily · Nov 2

UC innovations make TIME’s Best Inventions of 2026: How a pancreatic cancer drug and smarter wheelchair are changing lives?

From a pancreatic cancer drug that targets KRAS mutations to a smarter power wheelchair, University of California research is reaching beyond laboratories. Daraxonrasib, developed from discoveries at UCSF, received FDA approval in August. Meanwhile, UC Berkeley alumnus Tony Hong’s Strutt ev¹ uses sensors and voice controls to make everyday mobility…

The Economic Times · Oct 31

Relacorilant Triplet with Bevacizumab Shows 59% Response Rate in Phase 2 Single-Arm Platinum-Resistant Ovarian Cancer Trial

A three-drug regimen involving relacorilant shrank tumors in 59% of 95 women with recurrent platinum-resistant ovarian cancer, though the early company-reported findings require further independent review.

Medical Daily · Oct 29

Keytruda Gets Full FDA Approval for TMB-High Solid Tumors, but a Stricter 13-Mutation Cutoff Narrows Eligibility

The FDA converted Keytruda's accelerated approval for TMB-high solid tumors to traditional approval, raising the eligibility cutoff from 10 to 13 mutations per megabase.

Medical Daily · Oct 29

Read news from The Economist, FT, and more,
with one subscription

Savolitinib Plus Tagrisso Added About Five Months of Median Survival Over Chemo in MET-Driven Lung Cancer

Full SAFFRON results found that savolitinib plus Tagrisso improved overall and progression-free survival versus chemotherapy in EGFR-mutated lung cancer with MET changes, while highlighting important safety differences.

Medical Daily · Oct 28

Imdelltra Plus Imfinzi Cut Death Risk 58% for Patients with Extensive-Stage Small Cell Lung Cancer in Interim Results

Interim phase 3 results found that adding Amgen's Imdelltra to Imfinzi reduced the risk of death by 58% in extensive-stage small cell lung cancer, though the combination remains unapproved for maintenance treatment.

Medical Daily · Oct 27

Bowl For Ronnie: Ronnie James Dio cancer fund raises over $2m for research

Ronnie James Dio Cancer Fund donations have passed $2 million since the rock singer's death, giving his name a lasting role in medical research. The Ronnie James Dio Stand Up and Shout Cancer Fund is privately funded, with income from annual events and direct support from fans worldwide. Its money…

The Times of India · Oct 26

Pink headlines cancer benefit concert in San Diego, helps raise $8.25 million for research

Pink's concert at San Diego's Petco Park on May 15, 2026, raised $8.25 million for cancer research, drawing around 25,000 attendees, including cancer survivors. Organised by Curebound, the event took the total raised through its Concert for Cures series to more than $28 million across four concerts. Previous headliners included…

The Times of India · Oct 25

Ivonescimab Beat Imfinzi Regimen on Survival in China Bile Duct Cancer Trial, Akeso Says, as Details Await ESMO

Akeso says ivonescimab plus chemo improved survival over Imfinzi plus chemo in advanced biliary tract cancer in China. Full data will be presented at ESMO on Oct. 25.

Medical Daily · Oct 25

Pfizer's Atirmociclib Held Off Breast Cancer Progression for 9.4 Months Versus 6.6 After CDK4/6 Drugs Stopped Working

Atirmociclib delayed advanced breast cancer progression by 9.4 months vs. 6.6 in a Phase 2 trial after CDK4/6 drugs. Survival data are not yet available.

Medical Daily · Oct 25

Rs 1 lakh to Rs 30,000: Cancer immunotherapy gets cheaper, but will patients get the price benefit?

Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% rise in prescriptions over six months. Prices have fallen from over Rs 1 lakh to around Rs 30,000 per cycle, but hospital stocking practices could determine whether patients benefit from…

The Economic Times · Oct 25

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard · Oct 23

World’s first mRNA cancer jab for melanoma cuts risk of death by 42%

The study included more than 1,100 people with high-risk melanoma that had been surgically removed.

Medical Daily · Oct 23

One Yellow Eye in a 28-Year-Old with Lung Cancer Was a Tumor Inside the Eye, Not Jaundice

A 28-year-old with lung cancer had one yellow eye but normal liver tests. Scans showed his cancer had spread to the back of that eye.

Medical Daily · Oct 20

Jemperli Wins Accelerated FDA Approval for a Rectal Cancer Subtype as Most Trial Patients Avoided Surgery

FDA gave Jemperli accelerated approval for dMMR rectal cancer. Most trial patients skipped surgery, but the data are interim. What patients should ask.

Medical Daily · Oct 20

Merck and Moderna Prepare FDA Filing for Personalized mRNA Melanoma Vaccine Paired with Keytruda After Phase 3 Results

Merck and Moderna are preparing to seek FDA approval for a personalized mRNA melanoma vaccine used with Keytruda. No filing date has been set.

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Oct 19

Patients with Bile Duct Cancer Need FGFR2 Testing Before Lirafugratinib, but the Label Lists No FDA-Authorized Companion Test

Lirafugratinib treats bile duct cancer with FGFR2 changes, but its label lists no FDA-authorized test. Learn what patients need for testing and eye checks.

Medical Daily · Oct 15

FDA Expands Anktiva Approval to Papillary-Only Bladder Cancer That Resists BCG, Giving Patients a Nonsurgical Option

The FDA expanded Anktiva plus BCG to papillary-only bladder cancer that no longer responds to BCG. Here is who qualifies, what the data show, and what remains uncertain.

The Independent UK · Oct 14

Pope Leo XIV has lung cancer called adenocarcinoma. Here's what that means

Pope Leo XIV had the lower section of his right lung removed as doctors diagnosed him with the most common form of lung cancer

Medical Daily · Oct 14

BioNTech mRNA Therapy Plus Keytruda Missed Its Tumor Progression Goal in HPV-Linked Head and Neck Cancer

BioNTech's BNT113 with Keytruda did not slow HPV16-positive head and neck cancer in a Phase 2/3 first analysis. Survival data are still pending.

International Business Times UK · Oct 14

Famous Panty Liner Brand Faces Lawsuit As Hundreds of Women Allege Harm From Cancer-Causing Chemical

Hundreds of women have sued Carefree panty liner manufacturers, alleging the products contained PFOA and caused serious illnesses. The companies deny no liability has been established.

The Economic Times · Oct 14

Pope Leo cancer diagnosis: What is lung adenocarcinoma, symptoms, treatments & who are at risk

Pope Leo has been found to have lung adenocarcinoma, which is among the most common types of lung cancer. He recently had surgery to excise the lower lobe of his right lung. This cancer is frequently asymptomatic in the beginning stages, and known risk factors include both smoking and certain…

France 24 · Oct 14

What we know about Pope Leo XIV's lung cancer diagnosis

Pope Leo underwent surgery on Tuesday to remove a cancerous tumour from his right lung after saying that a nodule had been "detected at a very early stage". Following a "successful" operation, the Vatican said the 71-year-old pontiff would undergo additional testing.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

Environmental Protection Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.